462067-90-9 Usage
Uses
Used in Pharmaceutical Industry:
3-Isothiazolecarboxylicacid,4-amino-(9CI) is used as a building block for the synthesis of medicinal compounds, leveraging its unique chemical structure to develop new drugs with potential therapeutic applications. Its presence of an isothiazole ring and an amino group may contribute to the compound's biological activity, making it a promising candidate for drug discovery and development.
Used in Agricultural Industry:
In the agricultural sector, 3-Isothiazolecarboxylicacid,4-amino-(9CI) is used as a precursor in the synthesis of agrochemicals. Its potential biological activity could be harnessed to create new pesticides, herbicides, or other agricultural chemicals that can improve crop protection and yield. 3-Isothiazolecarboxylicacid,4-amino-(9CI)'s reactivity and chemical properties make it a valuable component in the development of innovative agrochemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 462067-90-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,2,0,6 and 7 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 462067-90:
(8*4)+(7*6)+(6*2)+(5*0)+(4*6)+(3*7)+(2*9)+(1*0)=149
149 % 10 = 9
So 462067-90-9 is a valid CAS Registry Number.
InChI:InChI=1/C4H4N2O2S/c5-2-1-9-6-3(2)4(7)8/h1H,5H2,(H,7,8)
462067-90-9Relevant academic research and scientific papers
IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
-
Page/Page column 90; 91, (2018/04/21)
Compounds of formula I or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFNa, by acting on Tyk-2 to cause signal transduction inhibition. The compounds of formula I are useful for the treatment of inflammatory or autoimmune diseases.
SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
-
Paragraph 00393, (2017/12/14)
The invention provides substituted imidazo[1,2-b]pyridazine compounds, substituted imidazo[1,5-b]pyridazine compounds, related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted imidazo[1,2-b]pyridazine compounds described herein include substituted imidazo[1,2-b]pyridazine-3-carboxamide compounds and variants thereof.
